Filtros : "IFSC111" "Future Medicinal Chemistry" Removido: "BIOFÍSICA" Limpar

Filtros



Refine with date range


  • Source: Future Medicinal Chemistry. Unidade: IFSC

    Subjects: DOENÇAS NEGLIGENCIADAS, PLANEJAMENTO DE FÁRMACOS, QUÍMICA MÉDICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Leonardo Luiz Gomes e ANDRICOPULO, Adriano Defini. Empowering neglected tropical disease drug discovery with translational medicinal chemistry. [Editorial]. Future Medicinal Chemistry. London: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.4155/fmc-2023-0140. Acesso em: 19 nov. 2024. , 2023
    • APA

      Ferreira, L. L. G., & Andricopulo, A. D. (2023). Empowering neglected tropical disease drug discovery with translational medicinal chemistry. [Editorial]. Future Medicinal Chemistry. London: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.4155/fmc-2023-0140
    • NLM

      Ferreira LLG, Andricopulo AD. Empowering neglected tropical disease drug discovery with translational medicinal chemistry. [Editorial] [Internet]. Future Medicinal Chemistry. 2023 ; 15( 12): 1015-1017.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc-2023-0140
    • Vancouver

      Ferreira LLG, Andricopulo AD. Empowering neglected tropical disease drug discovery with translational medicinal chemistry. [Editorial] [Internet]. Future Medicinal Chemistry. 2023 ; 15( 12): 1015-1017.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc-2023-0140
  • Source: Future Medicinal Chemistry. Unidade: IFSC

    Subjects: PSEUDOMONAS, BIOQUÍMICA, PLANEJAMENTO DE FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FROES, Thamires Quadros et al. A novel scaffold to fight Pseudomonas aeruginosa pyocyanin production: early steps to novel antivirulence drugs. Future Medicinal Chemistry, v. 12, n. 16, p. 1489-1503, 2020Tradução . . Disponível em: https://doi.org/10.4155/fmc-2019-0351. Acesso em: 19 nov. 2024.
    • APA

      Froes, T. Q., Guido, R. V. C., Metwally, K., & Castilho, M. S. (2020). A novel scaffold to fight Pseudomonas aeruginosa pyocyanin production: early steps to novel antivirulence drugs. Future Medicinal Chemistry, 12( 16), 1489-1503. doi:10.4155/fmc-2019-0351
    • NLM

      Froes TQ, Guido RVC, Metwally K, Castilho MS. A novel scaffold to fight Pseudomonas aeruginosa pyocyanin production: early steps to novel antivirulence drugs [Internet]. Future Medicinal Chemistry. 2020 ; 12( 16): 1489-1503.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc-2019-0351
    • Vancouver

      Froes TQ, Guido RVC, Metwally K, Castilho MS. A novel scaffold to fight Pseudomonas aeruginosa pyocyanin production: early steps to novel antivirulence drugs [Internet]. Future Medicinal Chemistry. 2020 ; 12( 16): 1489-1503.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc-2019-0351
  • Source: Future Medicinal Chemistry. Unidade: IFSC

    Subjects: APRENDIZADO COMPUTACIONAL, PLANEJAMENTO DE FÁRMACOS, INTELIGÊNCIA ARTIFICIAL

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Leonardo Luiz Gomes e ANDRICOPULO, Adriano Defini. From chemoinformatics to deep learning: an open road to drug discovery. [Editorial]. Future Medicinal Chemistry. London: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.4155/fmc-2018-0449. Acesso em: 19 nov. 2024. , 2019
    • APA

      Ferreira, L. L. G., & Andricopulo, A. D. (2019). From chemoinformatics to deep learning: an open road to drug discovery. [Editorial]. Future Medicinal Chemistry. London: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.4155/fmc-2018-0449
    • NLM

      Ferreira LLG, Andricopulo AD. From chemoinformatics to deep learning: an open road to drug discovery. [Editorial] [Internet]. Future Medicinal Chemistry. 2019 ; 11( 5): 371-374.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc-2018-0449
    • Vancouver

      Ferreira LLG, Andricopulo AD. From chemoinformatics to deep learning: an open road to drug discovery. [Editorial] [Internet]. Future Medicinal Chemistry. 2019 ; 11( 5): 371-374.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc-2018-0449
  • Source: Future Medicinal Chemistry. Unidade: IFSC

    Subjects: TRYPANOSOMA, PLANEJAMENTO DE FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PEREIRA, Glaécia A. N. et al. Benzimidazole inhibitors of the major cysteine protease of Trypanosoma brucei. Future Medicinal Chemistry, v. 11, n. 13, p. 1537-1551, 2019Tradução . . Disponível em: https://doi.org/10.4155/fmc-2018-0523. Acesso em: 19 nov. 2024.
    • APA

      Pereira, G. A. N., Santos, L. H., Wang, S. C., Martins, L. C., Villela, F. S., Liao, W., et al. (2019). Benzimidazole inhibitors of the major cysteine protease of Trypanosoma brucei. Future Medicinal Chemistry, 11( 13), 1537-1551. doi:10.4155/fmc-2018-0523
    • NLM

      Pereira GAN, Santos LH, Wang SC, Martins LC, Villela FS, Liao W, Dessoy MA, Dias LC, Andricopulo AD, Costa MAF, Nagem RAP, Caffrey CR, Liedl KR, Caffarena ER, Ferreira RS. Benzimidazole inhibitors of the major cysteine protease of Trypanosoma brucei [Internet]. Future Medicinal Chemistry. 2019 ; 11( 13): 1537-1551.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc-2018-0523
    • Vancouver

      Pereira GAN, Santos LH, Wang SC, Martins LC, Villela FS, Liao W, Dessoy MA, Dias LC, Andricopulo AD, Costa MAF, Nagem RAP, Caffrey CR, Liedl KR, Caffarena ER, Ferreira RS. Benzimidazole inhibitors of the major cysteine protease of Trypanosoma brucei [Internet]. Future Medicinal Chemistry. 2019 ; 11( 13): 1537-1551.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc-2018-0523
  • Source: Future Medicinal Chemistry. Unidade: IFSC

    Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, MODELAGEM MOLECULAR

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PAULI, Ivani et al. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors. Future Medicinal Chemistry, v. 9, n. 7, p. 641-657, 2017Tradução . . Disponível em: https://doi.org/10.4155/fmc-2016-0236. Acesso em: 19 nov. 2024.
    • APA

      Pauli, I., Ferreira, L. L. G., Souza, M. L., Oliva, G., Ferreira, R. S., Dessoy, M. A., et al. (2017). Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors. Future Medicinal Chemistry, 9( 7), 641-657. doi:10.4155/fmc-2016-0236
    • NLM

      Pauli I, Ferreira LLG, Souza ML, Oliva G, Ferreira RS, Dessoy MA, Slafer BW, Dias LC, Andricopulo AD. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors [Internet]. Future Medicinal Chemistry. 2017 ; 9( 7): 641-657.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc-2016-0236
    • Vancouver

      Pauli I, Ferreira LLG, Souza ML, Oliva G, Ferreira RS, Dessoy MA, Slafer BW, Dias LC, Andricopulo AD. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors [Internet]. Future Medicinal Chemistry. 2017 ; 9( 7): 641-657.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc-2016-0236
  • Source: Future Medicinal Chemistry. Unidade: IFSC

    Subjects: DOENÇAS NEGLIGENCIADAS (PESQUISA), ESQUISTOSSOMOSE, PLANEJAMENTO DE FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Leonardo Luiz Gomes e ANDRICOPULO, Adriano Defini e OLIVA, Glaucius. Target-based molecular modeling strategies for schistosomiasis drug discovery. Future Medicinal Chemistry, v. 7, n. 6, p. 753-764, 2015Tradução . . Disponível em: https://doi.org/10.4155/FMC.15.21. Acesso em: 19 nov. 2024.
    • APA

      Ferreira, L. L. G., Andricopulo, A. D., & Oliva, G. (2015). Target-based molecular modeling strategies for schistosomiasis drug discovery. Future Medicinal Chemistry, 7( 6), 753-764. doi:10.4155/FMC.15.21
    • NLM

      Ferreira LLG, Andricopulo AD, Oliva G. Target-based molecular modeling strategies for schistosomiasis drug discovery [Internet]. Future Medicinal Chemistry. 2015 ; 7( 6): 753-764.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/FMC.15.21
    • Vancouver

      Ferreira LLG, Andricopulo AD, Oliva G. Target-based molecular modeling strategies for schistosomiasis drug discovery [Internet]. Future Medicinal Chemistry. 2015 ; 7( 6): 753-764.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/FMC.15.21
  • Source: Future Medicinal Chemistry. Unidade: IFSC

    Subjects: TRYPANOSOMA, ENZIMAS, PLANEJAMENTO DE FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Leonardo Luiz Gomes e ANDRICOPULO, Adriano Defini. Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition. Future Medicinal Chemistry, v. 5, n. 15, p. 1753-1762, 2013Tradução . . Disponível em: https://doi.org/10.4155/fmc.13.140. Acesso em: 19 nov. 2024.
    • APA

      Ferreira, L. L. G., & Andricopulo, A. D. (2013). Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition. Future Medicinal Chemistry, 5( 15), 1753-1762. doi:10.4155/fmc.13.140
    • NLM

      Ferreira LLG, Andricopulo AD. Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition [Internet]. Future Medicinal Chemistry. 2013 ; 5( 15): 1753-1762.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc.13.140
    • Vancouver

      Ferreira LLG, Andricopulo AD. Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition [Internet]. Future Medicinal Chemistry. 2013 ; 5( 15): 1753-1762.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc.13.140
  • Source: Future Medicinal Chemistry. Unidade: IFSC

    Subjects: TRYPANOSOMA, DOENÇAS PARASITÁRIAS (ESTUDO;TRATAMENTO), PLANEJAMENTO DE FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MALUF, Fernando V. et al. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors. Future Medicinal Chemistry, v. No 2013, n. 17, p. 2019-2035, 2013Tradução . . Disponível em: https://doi.org/10.4155/fmc.13.166. Acesso em: 19 nov. 2024.
    • APA

      Maluf, F. V., Andricopulo, A. D., Oliva, G., & Guido, R. V. C. (2013). A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors. Future Medicinal Chemistry, No 2013( 17), 2019-2035. doi:10.4155/fmc.13.166
    • NLM

      Maluf FV, Andricopulo AD, Oliva G, Guido RVC. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors [Internet]. Future Medicinal Chemistry. 2013 ; No 2013( 17): 2019-2035.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc.13.166
    • Vancouver

      Maluf FV, Andricopulo AD, Oliva G, Guido RVC. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors [Internet]. Future Medicinal Chemistry. 2013 ; No 2013( 17): 2019-2035.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4155/fmc.13.166

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024